The Editor's Roundtable: High-Density Lipoprotein Cholesterol

American Journal of Cardiology

Volumn 99, Issue 12, 2007, Pages 1698-1705

  Friedewald Jr , Vincent E ^a   Brewer Jr , H Brian ^b   Grundy, Scott M ^c   Rader, Daniel J ^d   Roberts, William C ^e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TORCETRAPIB;

ACUTE CORONARY SYNDROME; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DNA POLYMORPHISM; DRUG INHIBITION; DRUG MEGADOSE; EXERCISE; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; LIPID DIET; LOW FAT DIET; MONOTHERAPY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SMOKING CESSATION;

EID: 34250003487     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.020     Document Type: Note

References (3)

1. NCEP Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
2. Kastelein JJP, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML, for the RADIANCE 1 Investigators. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. Clinical Trials.Gov number, NCT00136981 (ClinicalTrials.gov). (10.1056/NEJMoa071359). Available at: www.nejm.org. Accessed March 26, 2007.
3. Nissen S.E., Tardif J.-C., Nicholls S.J., Revkin J.H., Shear C.L., Duggan W.T., Ruzyllo W., Bachinsky W.B., Lasala G.P., Tuzcu E.M., and ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherasclerosis. N Engl J Med 356 (2007) 1304-1316